Lymphocyte and Cytokine Disturbances in Polymyalgia Rheumatica

Caractérisation Des Anomalies Immunologiques au Cours de la Pseudopolyarthrite rhizomélique et Effets du Traitement Par Tocilizumab

Pathophysiology of polymyalgia rheumatica (PMR) is ill defined. This study aims at characterizing immunological abnormalities in PMR patients, and to assess the effects of tocilizumab therapy on this abnormalities.

Comparison of PMR patients and matched control subjects.

Inclusion Criteria:

• PMR patient included in the TENOR study with samples available

Exclusion Criteria:

• Patient not included in the TENOR study